Literature DB >> 28455600

Protective multimodal analgesia with etoricoxib and spinal anesthesia in inguinal hernia repair: a randomized controlled trial.

Mostafa Somri1,2, Nasir Hawash3, Christopher Hadjittofi4, Marlain Ghantous-Toukan5, Riad Tome3, Marina Yodashkin3, Ibrahim Matter6,7.   

Abstract

BACKGROUND: Inguinal hernia repair is a common procedure, and can be performed under spinal anesthesia. Although adequate analgesia is crucial to postoperative recovery, the optimal protective analgesic regimen remains to be established.
PURPOSE: To investigate the effects of preoperative etoricoxib within a protective multimodal analgesic regimen with respect to pain control following open inguinal hernia repair.
METHODS: Sixty adult patients undergoing open inguinal hernia repair participated in a single-center, randomized, double-blinded, placebo-controlled trial in a general academic medical center. The intervention group (n = 30) received 120 mg of oral etoricoxib 1 h preoperatively, and 10-12 mg bupivacaine with 25 μg fentanyl as spinal anesthesia. The control group (n = 30) received oral placebo 1 h preoperatively, and spinal anesthesia as above. Postoperative Visual Analog Scale pain scores at rest and on active straight leg raise were recorded and analyzed.
RESULTS: Resting pain scores were significantly lower in the intervention than the control group at 16 h, 24 h, and on discharge (3.00 vs. 4.35; 1.57 vs. 4.00; 1.24 vs. 3.76, respectively; p < 0.05). Pain scores on active straight leg raise were significantly lower in the intervention than the control group at 16 h, 24 h, and on discharge (3.85 vs. 5.59, p < 0.01; 2.84 vs. 4.90, p < 0.05; 3.55 vs. 5.32, p < 0.05, respectively).
CONCLUSION: The addition of etoricoxib to spinal anesthesia as a multimodal protective regimen can improve pain control after inguinal hernia repair. The optimal dose and applicability to other operations remains to be established.

Entities:  

Keywords:  Etoricoxib; Hernia repair; Multimodal protective analgesia; Spinal anesthesia

Mesh:

Substances:

Year:  2017        PMID: 28455600     DOI: 10.1007/s00540-017-2368-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  30 in total

Review 1.  Preemptive analgesia.

Authors:  I Kissin
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

Review 2.  Etoricoxib.

Authors:  Deborah J Cochrane; Blair Jarvis; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Preemptive analgesia and local anesthesia as a supplement to general anesthesia: a review.

Authors:  Eliezer Kaufman; Joel B Epstein; Meir Gorsky; Douglass L Jackson; Avishag Kadari
Journal:  Anesth Prog       Date:  2005

Review 4.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

5.  Preoperative local infiltration with ropivacaine for postoperative pain relief after inguinal hernia repair. A randomised controlled trial.

Authors:  B Johansson; B Hallerbäck; A Stubberöd; T Janbu; B Edwin; H Glise; J H Solhaug
Journal:  Eur J Surg       Date:  1997-05

6.  The prevention of postoperative pain.

Authors:  P D Wall
Journal:  Pain       Date:  1988-06       Impact factor: 6.961

7.  Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty.

Authors:  J Toivonen; V-M Pitko; P H Rosenberg
Journal:  Acta Anaesthesiol Scand       Date:  2006-12-04       Impact factor: 2.105

8.  Postoperative pain after inguinal herniorrhaphy with different types of anesthesia.

Authors:  M Tverskoy; C Cozacov; M Ayache; E L Bradley; I Kissin
Journal:  Anesth Analg       Date:  1990-01       Impact factor: 5.108

9.  Evidence for a central component of post-injury pain hypersensitivity.

Authors:  C J Woolf
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

Review 10.  The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.

Authors:  Loren Laine
Journal:  Semin Arthritis Rheum       Date:  2002-12       Impact factor: 5.532

View more
  1 in total

1.  Preemptive Oral Etoricoxib on Health-Related Quality of Life after Mandibular Third Molar Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Long Xie; Zhi Li; Zheng-Jun Shang
Journal:  Biomed Res Int       Date:  2021-03-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.